Form 4: Hims & Hers CLO Exercises RSUs, Sells Shares for Tax

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, reported the vesting and exercise of Restricted Stock Units and the sale of shares to cover tax obligations.

Summary

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported transactions on December 15, 2025.
• Acquired 41,421 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Disposed of 22,817 shares of Class A Common Stock at a price of $36.25 per share to satisfy tax withholding obligations related to the RSU vesting.
• The transactions resulted in a net increase in directly owned Class A Common Stock for the reporting person, with 171,829 shares beneficially owned after the reported transactions.
• Multiple tranches of RSUs, totaling 41,421 units, vested and were converted into Class A Common Stock.
• Remaining unvested RSUs are subject to service-based vesting over a 4-year period in quarterly installments.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of executive compensation activity (RSU vesting and tax-related share sale) and does not contain information that significantly alters the company's fundamental outlook or sentiment.

Positives

• The vesting of RSUs indicates continued retention and compensation of a key executive, aligning their interests with long-term company performance.

Negatives

• The sale of 22,817 shares, while for tax purposes, represents a reduction in direct ownership by a key executive.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, focusing instead on executive compensation transactions.

Industry Context

This Form 4 filing is a routine disclosure of executive compensation activity, specifically the vesting of Restricted Stock Units and the subsequent sale of shares to cover tax liabilities. Such transactions are common across publicly traded companies as part of their executive compensation plans and do not inherently reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

• The RSU vesting and subsequent tax-related share sale are standard practices in executive compensation across various industries.
• The 4-year service-based vesting period is a common structure designed to retain key personnel.
• No specific comparable companies or projects are mentioned in the filing to allow for a direct comparison of results.

Related Party Transactions

• The reported transactions involve an executive (Soleil Boughton, Chief Legal Officer) of Hims & Hers Health, Inc. acquiring shares through RSU vesting and selling shares back to the issuer for tax withholding, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The sale of shares for tax purposes slightly reduces the executive's direct ownership but is a common practice. The continued vesting of RSUs aligns executive incentives with long-term shareholder value.
• Employees: The compensation structure for a key executive provides insight into the company's overall compensation philosophy.

Next Steps

• Continued quarterly vesting of remaining Restricted Stock Units for Soleil Boughton as per the service-based vesting schedules.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation activities, specifically the vesting of Restricted Stock Units and the sale of shares to cover tax obligations. These transactions are expected and do not provide new fundamental information that would warrant a change in investment recommendation. The core business operations and financial performance of Hims & Hers Health, Inc. remain the primary drivers for investment decisions.

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Soleil Boughton, Chief Legal Officer, Share Sale